4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-008917
Chairman and CEO bought 30,500 shares at an average $1.46 ($44,385)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-09 | Purchase | +23,500 | $1.45 | $34,075 | 11,187,406 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-10 | Purchase | +3,000 | $1.45 | $4,350 | 11,190,406 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-11 | Purchase | +4,000 | $1.49 | $5,960 | 11,194,406 | D |
| Open-market purchases · 30,500 sh · avg $1.46 · $44,385 | |||||||
Loading xslF345X03/doc4.xml…